Ra Pharmaceuticals, Inc. (Nasdaq: RARX) (“Ra Pharma”) today announced that it intends to offer and sell, subject to market and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Ra Pharmaceuticals (RARX) Prices 8.387M Share Common Offering at $15.50/ShDecember 12, 2018 5:49 AM Ra Pharmaceuticals Announces Proposed Public Offering of Common StockDecember 10, 2018 4:01 PM